Amivantamab
Amivantamab in ACC
Trisha Wise-Draper (investigator) · Phase 2 · Active, not recruiting · Enrollment 21
| Arm | Reported safety |
|---|---|
| Amivantamab | patients with serious adverse events: 7 patients (of 21), results posted |
A count stays a count. This page does not turn a count into a percent.